Syneos Health Balance Sheet Health
Financial Health criteria checks 3/6
Syneos Health has a total shareholder equity of $3.5B and total debt of $2.7B, which brings its debt-to-equity ratio to 75.8%. Its total assets and total liabilities are $8.1B and $4.6B respectively. Syneos Health's EBIT is $342.8M making its interest coverage ratio 3.1. It has cash and short-term investments of $91.2M.
Key information
75.8%
Debt to equity ratio
US$2.65b
Debt
| Interest coverage ratio | 3.1x |
| Cash | US$91.17m |
| Equity | US$3.49b |
| Total liabilities | US$4.58b |
| Total assets | US$8.08b |
Recent financial health updates
Does Syneos Health (NASDAQ:SYNH) Have A Healthy Balance Sheet?
Mar 10
Is Syneos Health (NASDAQ:SYNH) Using Too Much Debt?
Nov 28Is Syneos Health (NASDAQ:SYNH) A Risky Investment?
Aug 22We Think Syneos Health (NASDAQ:SYNH) Can Stay On Top Of Its Debt
May 19Is Syneos Health (NASDAQ:SYNH) A Risky Investment?
Feb 18Recent updates
Is Now The Time To Look At Buying Syneos Health, Inc. (NASDAQ:SYNH)?
Mar 29Does Syneos Health (NASDAQ:SYNH) Have A Healthy Balance Sheet?
Mar 10Is Syneos Health, Inc. (NASDAQ:SYNH) Trading At A 40% Discount?
Feb 20Should You Investigate Syneos Health, Inc. (NASDAQ:SYNH) At US$34.33?
Dec 20Is Syneos Health (NASDAQ:SYNH) Using Too Much Debt?
Nov 28Here's Why Syneos Health (NASDAQ:SYNH) Has Caught The Eye Of Investors
Nov 01Syneos, Datavant expand partnership on data analytics for clinical trials
Oct 11Syneos Health falls 13% after update on outlook
Sep 13When Should You Buy Syneos Health, Inc. (NASDAQ:SYNH)?
Sep 08Is Syneos Health (NASDAQ:SYNH) A Risky Investment?
Aug 22Syneos Health Q2 2022 Earnings Preview
Aug 01With EPS Growth And More, Syneos Health (NASDAQ:SYNH) Makes An Interesting Case
Jul 19Syneos: Upside Could Be Priced In, Valuations Unsupportive
Jul 15Is There An Opportunity With Syneos Health, Inc.'s (NASDAQ:SYNH) 49% Undervaluation?
Jun 18Is Now The Time To Look At Buying Syneos Health, Inc. (NASDAQ:SYNH)?
Jun 03We Think Syneos Health (NASDAQ:SYNH) Can Stay On Top Of Its Debt
May 19Do Syneos Health's (NASDAQ:SYNH) Earnings Warrant Your Attention?
Apr 08Syneos Health: Upside Opportunity After Unexpected Correction In CRO Market, M&A Rumors
Mar 27Is Now An Opportune Moment To Examine Syneos Health, Inc. (NASDAQ:SYNH)?
Mar 05Is Syneos Health (NASDAQ:SYNH) A Risky Investment?
Feb 18Are Investors Undervaluing Syneos Health, Inc. (NASDAQ:SYNH) By 39%?
Feb 03With EPS Growth And More, Syneos Health (NASDAQ:SYNH) Is Interesting
Jan 04Syneos Health's Double-Digit Revenue Growth Sets The Tone For A Strong 2022
Dec 03Is It Too Late To Consider Buying Syneos Health, Inc. (NASDAQ:SYNH)?
Dec 03Financial Position Analysis
Short Term Liabilities: SYNH's short term assets ($2.0B) exceed its short term liabilities ($1.6B).
Long Term Liabilities: SYNH's short term assets ($2.0B) do not cover its long term liabilities ($3.0B).
Debt to Equity History and Analysis
Debt Level: SYNH's net debt to equity ratio (73.2%) is considered high.
Reducing Debt: SYNH's debt to equity ratio has reduced from 101.8% to 75.8% over the past 5 years.
Debt Coverage: SYNH's debt is not well covered by operating cash flow (9.5%).
Interest Coverage: SYNH's interest payments on its debt are well covered by EBIT (3.1x coverage).